FDA Orange Book

Generic for Uceris

Uceris contains budesonide. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.

Source: FDA Orange Book data file dated 2026-10-09. Publisher page

Yes. The generic name for Uceris is budesonide. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.

Run it in Rivvi

Map Uceris and your other top fills to their generics

Every strength in RxNorm, with brands that have no generic flagged.

Build the map

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Uceris products in the Orange Book

Uceris products and approved generics
Form and routeStrengthBrand statusBrand TEActive genericsGeneric TE codes
aerosol, foam, rectal2MG/ACTUATIONMarketed (Rx)AB1AB
tablet, extended release, oral9MGMarketed (Rx)AB2AB

NDA 205613, 203634, held by SALIX PHARMACEUTICALS INC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.

Approved generic budesonide

Approved generic versions of Uceris
CompanyANDATE codeApprovedStrengths
ACTAVIS LABORATORIES FL INC205457AB (A-rated, therapeutically equivalent)July 3, 20189MG
MYLAN PHARMACEUTICALS INC208851AB (A-rated, therapeutically equivalent)September 17, 20209MG
PADAGIS ISRAEL PHARMACEUTICALS LTD215328AB (A-rated, therapeutically equivalent)April 12, 20232MG/ACTUATION

Uceris patents

Patents listed for Uceris
PatentExpiresCoversUse codeNDA
9192581September 7, 2031Drug productU-1325203634
8895064September 7, 2031Drug productNone203634
10660858September 7, 2031Drug productNone203634
10307375September 7, 2031Drug productNone203634
9132093September 7, 2031Drug productNone203634

Uceris NDC codes

Questions

Is there a generic for Uceris?

Yes. The generic name for Uceris is budesonide. 3 companies hold an active FDA approval (ANDA) for a generic version in the Orange Book. Therapeutic equivalence codes: AB.

What is the generic name for Uceris?

The active ingredient in Uceris is budesonide, per the FDA Orange Book.

When does the Uceris patent expire?

The last patent listed for Uceris in the Orange Book expires September 7, 2031. A listed patent expiry date is not a generic launch date.

What does a therapeutic equivalence code mean?

In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.

More on Uceris and Budesonide

Try it on your own data today.

Free to start. Most teams are using it the same day.